Bayer Appoints Bill Anderson as CEO, Effective June 1 Local time on February 8, news came that the Supervisory Board of Bayer AG has appointed Bill Anderson as the company’s Chief Executive Officer, effective June 1. He will join Bayer on April 1 as a member of the Management Board. Werner Baumann, the current CEO of Bayer, will work closely with him and retire at the end of May after ensuring a smooth transition.
According to the introduction, Bill Anderson is a chemical engineer who has held multiple leadership positions in the life sciences industry over the past 25 years. During his tenure as CEO of Roche's pharmaceuticals division, he successfully led a comprehensive transformation program, launching many new products and achieving significant revenue growth. Prior to this role, Anderson served as the CEO of Genentech, one of the pioneering companies in the biotechnology field.